Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

45.33
-0.2800-0.61%
Post-market: 45.330.00000.00%19:59 EDT
Volume:7.61M
Turnover:344.95M
Market Cap:200.50B
PE:11.32
High:45.61
Open:45.28
Low:44.95
Close:45.61
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:0.68
T/O Rate:0.24%
Dividend:1.72
Dividend Rate:3.80%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.16
PE(LYR):12.52

Loading ...

Eli Lilly Faces Legal Action from Novo Nordisk Over Alleged Misleading Weight-Loss Drug Advertisements

Stock News
·
Jul 21

Novo Nordisk Says Mismatched Diabetes Drug Ads Triggered Lawsuit Vs. Lilly

Dow Jones
·
Jul 21

Novo Nordisk files lawsuit against ‘misleading’ GLP-1 ads from Eli Lilly

TIPRANKS
·
Jul 21

Novo Nordisk Sues Eli Lilly Over Zepbound, Mounjaro Advertising

MT Newswires Live
·
Jul 21

Novo Nordisk Sues Eli Lilly Over Allegedly Misleading GLP-1 Advertising

MT Newswires Live
·
Jul 21

Novo Nordisk Sues Eli Lilly in U.S. Federal Court, Alleging Claim Under the Lanham Act, Court Records Show

THOMSON REUTERS
·
Jul 21

The world is desperate for weight-loss drugs. But Big Pharma can’t advertise them

CNN Business
·
Jul 21

Novo Nordisk price target raised to DKK 330 from DKK 290 at Citi

TIPRANKS
·
Jul 21

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 21

Update: Novo Nordisk's Wegovy Approved in India for Fatty Liver Disease Treatment

MT Newswires Live
·
Jul 20

Novo Nordisk (0QIU) Receives a Hold from Deutsche Bank

TIPRANKS
·
Jul 20

Novo Nordisk Guidance in Focus

Dow Jones
·
Jul 20

Trump's FDA May Soon Back Peptides. Should You Buy In?

Dow Jones
·
Jul 18

Novo Nordisk’s CagriSema Trial Wraps Up: What Completed Phase 3 Data Could Mean for NVO

TIPRANKS
·
Jul 18

Novo Nordisk to Launch Lower-cost Ozempic Copy in South Africa

Reuters
·
Jul 18

Novo Nordisk A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 18

European Equities Mixed in Friday Trading; ASML to Give Staff One-Time Bonus

MT Newswires Live
·
Jul 17

European Pharma Stocks' Underperformance Shouldn't Last

Dow Jones
·
Jul 17

Market Chatter: Novo Nordisk's Wegovy Approved for Fatty Liver Disease Treatment by India's Drug Regulator

MT Newswires Live
·
Jul 17

Cboe data shows mixed options sentiment in Novo Nordisk with shares up 2.11%

TIPRANKS
·
Jul 17